涿州市新农合患者进展性脑梗死及缺血性脑卒中复发的相关危险因素分析

目的分析涿州市新农合患者进展性脑梗死及缺血性脑卒中复发的相关危险因素。方法选择保定第二中心医院2005年6月至2011年12月收治的涿州市新农合进展性脑梗死患者220例(A组)及缺血性脑卒中复发患者349例(B组),另外选择同期收治的稳定性脑梗死患者220例(C组)及缺血性脑卒中初发患者414例(D组),采用Logistic回归分析进展性脑梗死及缺血性脑卒中复发的相关危险因素。结果收缩压、舒张压、高血压病史、糖尿病病史、发热、椎动脉狭窄均为进展性脑梗死患者的独立危险因素(P<0.05);血压控制不良、颈动脉斑块、糖尿病、高纤维蛋白原、高血清同型半胱氨酸、心房颤动、卒中家族史为缺血性脑卒中复发的独立危险因素(P<0.05)。结论根据涿州市新农合患者进展性脑梗死及缺血性脑卒中复发的相关危险因素,实施早期防治措施,可降低进展性脑梗死和缺血性脑卒中复发的发生率,最终降低患者的病死率和致残率。

The Analysis of Risk Factors of Progressive Cerebral Infarction and Ischemic Stroke Recurrence for Patients from the New Rural Cooperative Medical Care System in Zhuozhou City

Objective To analyze the risk factors of progressive cerebral infarction and ischemic stroke recur- rence for patients from new rural cooperative medical care system in Zhuozhou City. Methods A total of 220 patients（ group A） with cerebral infarction and 349 patients（ group B） with recurrent ischemic stroke hospitalized in Baoding Second Central Hospital during Jun. 2005 and Dec. 2011 were selected,220 patients （ group C） with stable cerebral infarction and 414 patients（ group D） with incipient ischemic stroke during the same time were also selected. The related risk factors of the progressive cerebral infarction and recurrent ischemic stroke were analyzed by Logistic regression methods. Results The systolic blood pressure, diastolic blood pressure, history of hyperten- sion, history of diabetes, fever, vertebral artery stenosis were independent risk factors of patients with progressive cerebral infarction （ P 〈 0.05 ）. The poor control of blood pressure, carotid artery plaque, diabetes, high fibrinogen, high hcy, atrial fibrillation, family history of stroke were independent risk factors for ischemic stroke recurrence （ P 〈 0.05 ）. Conclusion Early prevention and treatment measures should be implemented according to the risk factors of progressive cerebral infarction and ischemic stroke recurrence for patients from the new rural cooperative medical systear in Zbuozhou city,whlch could reduce the incidence of progressive cerebral infarction and ischemic stroke recurrence, and ultimately reduce the morbidity and mortality.